Investors
- Home
- Investors
- Contacts
- Contact
Event News
Financial Information
Shareholders
Corporate Governance
Gluphor 50/850 mg Film-Coated Tablets
Gluphor 50/500 mg Film-Coated Tablets
Gaty film-coated tablet 600mg
Ferich Forte Capsules
Fendown F.C. Tablets 160mg
Doros CORS Tablets 4mg
Donvex CORS Tablets 9 mg
Donvex CORS Tablets 6 mg
Donvex CORS Tablets 3 mg
DonGlu Tablets 4mg
ZOLOTIN FILM COATED TABLETS 20MG
Zoliton Tablets 10/20mg
Zoliton Tablets 10/10mg
Zerocal Capsules 120mg
Veinlax F.C. Tablets 500mg
Uridin F.C. Tablets 2mg
Disfect F.C. Tablets 250mg
Thamic Otic Solution 0.3%
Tamokas Prolonged Release Tablets 0.4mg
Dephos F.C. Tablets 400mg
Tamokas D Tablets 0.4mg
Tamokas D Tablets 0.2mg
Taglu F.C. Tablets 100mg
Standfil Tablets 5mg
Standfil Tablets 20mg
DAMPURINE TABLETS 25MG
Sordur Controlled-Release Tablets 60mg
Rofew I.V. infusion solution 200 mg/ml
Comide Extended Release Tablets 36mg
Relung F.C. Tablets 20mg
Comide Extended Release Tablets 27mg
Pitanxo F.C. Tablets 4mg
Comide Extended Release Tablets 18mg
Pinvio Tablets 12.5mg
Ozyn Soft Gelatin Capsules 20mg
Ozyn Soft Gelatin Capsules 10mg
Cinaca F.C. Tablets 25mg
Norxicam Rapid F.C. Tablets 8mg
Chalian Powder
Norepine Injection
Nophos powder for oral suspension
Carvio Tablets 6.25mg
Nophos F.C. Tablet 800mg
Carvio Tablet 25mg
NILASEN TABLETS 24MG
NILASEN TABLETS 16MG
Niferos OROS 30mg
Mifiry Injection
BUSACON TABLETS 0.125MG
Boseten Soft Capsules 150mg
Boseten Soft Capsules 100mg
MELSTATIN TABLETS 20MG
Bojum Intravenous Injection 0.25g, 0.5g
Melstatin tablet 40mg
Ariple Tablets 20mg
Melosa 5/40 mg F.C. Tablets
Ariple Tablets 10mg
Limus F.C. Tablets 25 mg
Arika Tablets 15mg
Lecadopa 25/100 Tablets
Kuzem Powder
Anxotos Tablets 30mg
Kludone MR Tablets 60mg
Anxotos Tablets 15 mg
Anxomine Tablet 2mg
HYTONIN TABLETS 10MG
Anxolipo F.C. Tablets 40mg
Anxolipo F.C. Tablet 10 mg
Anxolightor F.C. Tablets 20 mg
Anxokast F.C. Tablets 10mg
Anxokast chewable tablets 4mg
Anxokast Chewable Tablet 5mg
Anfero Film-Coated Tablets 360 mg
Contact
Spokesman: Stacy Sun
TEL: (02) 2054-2121
Email: investor@anxo.com.tw